Disseminated Mycobacterium chelonae infection in kidney transplant patients

被引:0
作者
Yaseen, Mustafa Muwafaq [1 ]
Spencer, Sebastian [2 ]
Bhandari, Sunil [2 ]
机构
[1] Hull Univ Teaching Hosp NHS Trust, Kingston Upon Hull, England
[2] Hull Univ Teaching Hosp NHS Trust, Nephrol, Kingston Upon Hull, East Riding Of, England
关键词
Renal system; Renal transplantation; Infectious diseases;
D O I
10.1136/bcr-2024-260095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mycobacterium chelonae (M. chelonae) is a member of the rapidly growing non-tuberous mycobacteria and can cause disseminated tissue infection, particularly, in the limbs. We reviewed medical records of two kidney transplant patients. We describe their background disease and transplantation details, with the use of immunosuppressive medication. We also discuss the presentation of M. chelonae infection and treatment. Both patients received deceased brain-dead donor kidney transplants for end-stage kidney disease. Both developed cutaneous manifestations of M. chelonae, progressing to disseminated infections. Case 1 was on low-dose prednisolone (2 mg) and tacrolimus, whereas, case 2 received varying doses of prednisolone (5-40 mg) and sirolimus. Antibiotics advised by infectious disease specialists were initiated within a month of skin lesion appearance. Effective treatment involved a combination of antibiotics such as clarithromycin, azithromycin, linezolid and tigecycline. These cases underline the efficacy of clarithromycin and azithromycin as long-term antibiotic treatment, with linezolid and tigecycline for management of acute dissemination.
引用
收藏
页数:5
相关论文
共 10 条
[1]  
Akram SM., 2022, Mycobacterium Chelonae
[2]   Drug Interactions between Antimicrobial and. Immunosuppressive Agents in Solid Organ Transplant Recipients [J].
Bhagat, Vikas ;
Pandit, Rahul A. ;
Ambapurkar, Shwetha ;
Sengar, Manju ;
Kulkarni, Atul P. .
INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (01) :67-76
[3]   Rapidly Growing Mycobacteria [J].
Brown-Elliott, Barbara A. ;
Philley, Julie V. .
MICROBIOLOGY SPECTRUM, 2017, 5 (01)
[4]   Nontuberculous Mycobacterial Disease Prevalence and Risk Factors: A Changing Epidemiology [J].
Cassidy, P. Maureen ;
Hedberg, Katrina ;
Saulson, Ashlen ;
McNelly, Erin ;
Winthrop, Kevin L. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (12) :E124-E129
[5]  
Gui Jing, 2013, Zhonghua Jie He He Hu Xi Za Zhi, V36, P567
[6]   Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases [J].
Lange, Christoph ;
Bottger, Erik C. ;
Cambau, Emmanuelle ;
Griffith, David E. ;
Guglielmetti, Lorenzo ;
van Ingen, Jakko ;
Knight, Shandra L. ;
Marras, Theodore K. ;
Olivier, Kenneth N. ;
Santin, Miguel ;
Stout, Jason E. ;
Tortoli, Enrico ;
Wagner, Dirk ;
Winthrop, Kevin ;
Daley, Charles L. .
LANCET INFECTIOUS DISEASES, 2022, 22 (07) :E178-E190
[7]   Medical Tourism and Postoperative Infections: A Systematic Literature Review of Causative Organisms and Empiric Treatment [J].
Padilla, Pablo ;
Ly, Priscilla ;
Dillard, Rachel ;
Boukovalas, Stefanos ;
Zapata-Sirvent, Ramon ;
Phillips, Linda G. .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2018, 142 (06) :1644-1651
[8]   Mycobacterial infection in a series of 1261 renal transplant recipients [J].
Queipo, JA ;
Broseta, E ;
Santos, M ;
Sánchez-Plumed, J ;
Budía, A ;
Jiménez-Cruz, F .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (06) :518-525
[9]   Case of atypical cutaneous Mycobacteriumchelonae infection in patient of systemic lupus erythematosus after cyclophosphamide therapy [J].
Rasool, Sheraz ;
Afifi, Amr ;
De Lord, Denise .
BMJ CASE REPORTS, 2019, 12 (12)
[10]   SKIN, SOFT-TISSUE, AND BONE-INFECTIONS DUE TO MYCOBACTERIUM-CHELONAE-CHELONAE - IMPORTANCE OF PRIOR CORTICOSTEROID-THERAPY, FREQUENCY OF DISSEMINATED INFECTIONS, AND RESISTANCE TO ORAL ANTIMICROBIALS OTHER THAN CLARITHROMYCIN [J].
WALLACE, RJ ;
BROWN, BA ;
ONYI, GO .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) :405-412